Literature DB >> 14623959

Delivery of antimicrobials into parasites.

B U Samuel1, B Hearn, D Mack, P Wender, J Rothbard, M J Kirisits, E Mui, S Wernimont, C W Roberts, S P Muench, D W Rice, S T Prigge, A B Law, R McLeod.   

Abstract

To eliminate apicomplexan parasites, inhibitory compounds must cross host cell, parasitophorous vacuole, and parasite membranes and cyst walls, making delivery challenging. Here, we show that short oligomers of arginine enter Toxoplasma gondii tachyzoites and encysted bradyzoites. Triclosan, which inhibits enoyl-ACP reductase (ENR), conjugated to arginine oligomers enters extracellular tachyzoites, host cells, tachyzoites inside parasitophorous vacuoles within host cells, extracellular bradyzoites, and bradyzoites within cysts. We identify, clone, and sequence T. gondii enr and produce and characterize enzymatically active, recombinant ENR. This enzyme has the requisite amino acids to bind triclosan. Triclosan released after conjugation to octaarginine via a readily hydrolyzable ester linkage inhibits ENR activity, tachyzoites in vitro, and tachyzoites in mice. Delivery of an inhibitor to a microorganism via conjugation to octaarginine provides an approach to transporting antimicrobials and other small molecules to sequestered parasites, a model system to characterize transport across multiple membrane barriers and structures, a widely applicable paradigm for treatment of active and encysted apicomplexan and other infections, and a generic proof of principle for a mechanism of medicine delivery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623959      PMCID: PMC283583          DOI: 10.1073/pnas.2436169100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  ChloroP, a neural network-based method for predicting chloroplast transit peptides and their cleavage sites.

Authors:  O Emanuelsson; H Nielsen; G von Heijne
Journal:  Protein Sci       Date:  1999-05       Impact factor: 6.725

2.  Polyarginine enters cells more efficiently than other polycationic homopolymers.

Authors:  D J Mitchell; D T Kim; L Steinman; C G Fathman; J B Rothbard
Journal:  J Pept Res       Date:  2000-11

3.  Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.

Authors:  R McLeod; S P Muench; J B Rafferty; D E Kyle; E J Mui; M J Kirisits; D G Mack; C W Roberts; B U Samuel; R E Lyons; M Dorris; W K Milhous; D W Rice
Journal:  Int J Parasitol       Date:  2001-02       Impact factor: 3.981

4.  Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase.

Authors:  Remo Perozzo; Mack Kuo; Amar bir Singh Sidhu; Jacob T Valiyaveettil; Robert Bittman; William R Jacobs; David A Fidock; James C Sacchettini
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

5.  Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase.

Authors:  E Zuther; J J Johnson; R Haselkorn; R McLeod; P Gornicki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

6.  Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation.

Authors:  J B Rothbard; S Garlington; Q Lin; T Kirschberg; E Kreider; P L McGrane; P A Wender; P A Khavari
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

7.  The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.

Authors:  P A Wender; D J Mitchell; K Pattabiraman; E T Pelkey; L Steinman; J B Rothbard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

8.  Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.

Authors:  N Surolia; A Surolia
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

Review 9.  Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa.

Authors:  C W Roberts; R McLeod; D W Rice; M Ginger; M L Chance; L J Goad
Journal:  Mol Biochem Parasitol       Date:  2003-02       Impact factor: 1.759

10.  Expression, purification and crystallization of the Plasmodium falciparum enoyl reductase.

Authors:  Stephen P Muench; John B Rafferty; Rima McLeod; David W Rice; Sean T Prigge
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-06-27
View more
  30 in total

1.  Maternal inheritance and stage-specific variation of the apicoplast in Toxoplasma gondii during development in the intermediate and definitive host.

Authors:  David J P Ferguson; Fiona L Henriquez; Michael J Kirisits; Stephen P Muench; Sean T Prigge; David W Rice; Craig W Roberts; Rima L McLeod
Journal:  Eukaryot Cell       Date:  2005-04

2.  Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice.

Authors:  Paul A Wender; Elena A Goun; Lisa R Jones; Thomas H Pillow; Jonathan B Rothbard; Rajesh Shinde; Christopher H Contag
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

3.  Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.

Authors:  Ernest J Mui; David Jacobus; Wilbur K Milhous; Guy Schiehser; Honghue Hsu; Craig W Roberts; Michael J Kirisits; Rima McLeod
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Targeting protein translation, RNA splicing, and degradation by morpholino-based conjugates in Plasmodium falciparum.

Authors:  Aprajita Garg; Donna Wesolowski; Dulce Alonso; Kirk W Deitsch; Choukri Ben Mamoun; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

5.  Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections.

Authors:  Bo-Shiun Lai; William H Witola; Kamal El Bissati; Ying Zhou; Ernest Mui; Alina Fomovska; Rima McLeod
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

6.  Lipidomic analysis of Toxoplasma gondii reveals unusual polar lipids.

Authors:  Ruth Welti; Ernie Mui; Alexis Sparks; Sarah Wernimont; Giorgis Isaac; Michael Kirisits; Mary Roth; Craig W Roberts; Cyrille Botté; Eric Maréchal; Rima McLeod
Journal:  Biochemistry       Date:  2007-11-08       Impact factor: 3.162

7.  Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.

Authors:  Gang Cheng; Stephen P Muench; Ying Zhou; Gustavo A Afanador; Ernest J Mui; Alina Fomovska; Bo Shiun Lai; Sean T Prigge; Stuart Woods; Craig W Roberts; Mark R Hickman; Patty J Lee; Susan E Leed; Jennifer M Auschwitz; David W Rice; Rima McLeod
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

8.  Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.

Authors:  Gustavo A Afanador; Stephen P Muench; Martin McPhillie; Alina Fomovska; Arne Schön; Ying Zhou; Gang Cheng; Jozef Stec; Joel S Freundlich; Hong-Ming Shieh; John W Anderson; David P Jacobus; David A Fidock; Alan P Kozikowski; Colin W Fishwick; David W Rice; Ernesto Freire; Rima McLeod; Sean T Prigge
Journal:  Biochemistry       Date:  2013-12-13       Impact factor: 3.162

9.  Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo.

Authors:  Ying Zhou; Alina Fomovska; Stephen Muench; Bo-Shiun Lai; Ernest Mui; Rima McLeod
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

10.  Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.

Authors:  Jozef Stec; Alina Fomovska; Gustavo A Afanador; Stephen P Muench; Ying Zhou; Bo-Shiun Lai; Kamal El Bissati; Mark R Hickman; Patty J Lee; Susan E Leed; Jennifer M Auschwitz; Caroline Sommervile; Stuart Woods; Craig W Roberts; David Rice; Sean T Prigge; Rima McLeod; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2013-06-14       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.